Quantum Biopharma Ltd Quick Ratio (HUGE) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Quantum Biopharma Ltd   (NASDAQ: HUGE)

Quantum Biopharma Ltd 's Quick Ratio

HUGE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Quantum Biopharma Ltd 's Cash & cash equivalent grew by 327.26 % in the Q4 2025 sequentially, faster than Current Liabilities, this led to improvement in Quantum Biopharma Ltd 's Quick Ratio to 0.46, Quick Ratio remained below Quantum Biopharma Ltd average.

Within Major Pharmaceutical Preparations industry 462 other companies have achieved higher Quick Ratio than Quantum Biopharma Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 0 to 3068.

Explain Quick Ratio?
How much Cash & cash equivalents HUGE´s has?
What are HUGE´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HUGE Quick Ratio (Dec 31 2025)
Q3		 (Sep 30 2025)
Q2		 (Jun 30 2025)
Q1		 (Mar 31 2025)
Q4		 (Dec 31 2024)
Q3
Y / Y Current Liabilities Change -62.12 % -59.07 % -71.23 % -64.71 % 26.03 %
Y / Y Cash & cash equivalent Change -68.22 % -85.71 % -54.71 % 164.49 % 117.47 %
Quick Ratio MRQ 0.46 0.11 0.47 1.49 0.54
HUGE's Total Ranking # 3068 # 0 # 1946 # #
Seq. Current Liabilities Change 2.31 % 28.03 % 35.46 % -78.65 % 10.56 %
Seq. Cash & cash equivalent Change 327.26 % -70.22 % -57.43 % -41.32 % 92.16 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 463
Healthcare Sector # 866
Overall Market # 3068


Quick Ratio Statistics
High Average Low
12.12 2.03 0.11
(Dec 31 2018)   (Sep 30 2025)




Financial Statements
Quantum Biopharma Ltd 's Current Liabilities $ 4 Millions Visit HUGE's Balance sheet
Quantum Biopharma Ltd 's Cash & cash equivalent $ 2 Millions Visit HUGE's Balance sheet
Source of HUGE's Sales Visit HUGE's Sales by Geography


Cumulative Quantum Biopharma Ltd 's Quick Ratio

HUGE's Quick Ratio for the trailling 12 Months

HUGE Quick Ratio

 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -64.39 % -43.39 % -14.55 % 40.34 % 72.8 %
Y / Y Cash & cash equivalent TTM Growth -46.43 % 8.97 % 39.22 % 66.03 % 24.71 %
Quick Ratio TTM 0.53 0.55 0.53 0.46 0.35
Total Ranking TTM # 4123 # 0 # 3686 # #
Seq. Current Liabilities TTM Growth -33.17 % -22.2 % -22.93 % -11.14 % 6.24 %
Seq. Cash & cash equivalent TTM Growth -35.7 % -18.92 % -11.35 % 15.91 % 30.8 %

Quick ratio ranking by company, industry and sector >> Back to HUGE Financial Strength Comparisons >> Go to Compare HUGE Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in HUGE's Current Liabilities to $4.18 millions, cumulative Quick Ratio to 0.53 below the HUGE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 489 other companies have achieved higher Quick Ratio than Quantum Biopharma Ltd . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 0 to 4123.

Explain Quick Ratio?
How much Cash & cash equivalents HUGE´s has?
What are HUGE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 490
Healthcare Sector # 1008
Within the Market # 4123


trailing twelve months Quick Ratio Statistics
High Average Low
4.05 1.68 0.31
(Dec 31 2021)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Vireo Growth Inc.  1.25 $ 103.230  Millions$ 82.545  Millions
Vanda Pharmaceuticals Inc   1.24 $ 84.851  Millions$ 68.297  Millions
Amicus Therapeutics inc   1.23 $ 293.536  Millions$ 237.828  Millions
Nkarta Inc   1.23 $ 39.634  Millions$ 32.122  Millions
Immunoprecise Antibodies Ltd   1.21 $ 7.919  Millions$ 6.527  Millions
Puma Biotechnology Inc   1.20 $ 97.528  Millions$ 81.253  Millions
Greenwich Lifesciences Inc   1.20 $ 6.178  Millions$ 5.151  Millions
Nature s Sunshine Products inc   1.20 $ 93.891  Millions$ 78.538  Millions
Nanoviricides inc   1.19 $ 1.559  Millions$ 1.307  Millions
Keenova Therapeutics Plc  1.16 $ 812.800  Millions$ 698.700  Millions
Longeveron Inc   1.14 $ 4.661  Millions$ 4.087  Millions
Akebia Therapeutics Inc   1.13 $ 184.844  Millions$ 162.938  Millions
Rockwell Medical inc   1.13 $ 10.848  Millions$ 9.580  Millions
Nervgen Pharma Corp   1.12 $ 16.905  Millions$ 15.115  Millions
Alkermes Plc   1.08 $ 588.215  Millions$ 543.437  Millions
Kamada Ltd   1.07 $ 75.469  Millions$ 70.636  Millions
Cingulate Inc   1.06 $ 10.953  Millions$ 10.313  Millions
Dar Bioscience Inc   1.04 $ 24.711  Millions$ 23.686  Millions
Ani Pharmaceuticals Inc  1.02 $ 285.585  Millions$ 279.060  Millions
Xeris Biopharma Holdings Inc   1.01 $ 111.042  Millions$ 109.574  Millions
Evotec Se  1.01 $ 360.490  Millions$ 356.680  Millions
Bausch Health Companies Inc   1.01 $ 1,309.000  Millions$ 1,297.000  Millions
Royalty Pharma Plc  1.00 $ 637.496  Millions$ 636.211  Millions
Mannkind Corporation  1.00 $ 171.346  Millions$ 171.031  Millions
Phathom Pharmaceuticals Inc   0.98 $ 129.972  Millions$ 132.044  Millions
Zymeworks Inc   0.97 $ 41.157  Millions$ 42.318  Millions
Elite Pharmaceuticals Inc   0.96 $ 11.407  Millions$ 11.840  Millions
Zomedica Corp   0.95 $ 9.017  Millions$ 9.449  Millions
Ensysce Biosciences Inc   0.94 $ 4.310  Millions$ 4.568  Millions
Organogenesis Holdings Inc   0.94 $ 93.679  Millions$ 100.124  Millions

Date modified: 2026-06-23T19:22:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.